Anant Labs

Palbociclib

CAS 571190-30-2

Visão geral

Palbociclib, sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Palbociclib was the first CDK4/6 inhibitor to be approved as a cancer therapy

A Anant Labs fabrica e fornece impurezas de Palbociclib de alta qualidade para o mercado global. Nossas impurezas EP de Palbociclib são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.

Ingrediente Farmacêutico Ativo

Impurezas (15)